| Secondary |
| Atrial Fibrillation |
18.3% |
| Drug Use For Unknown Indication |
11.3% |
| Bronchitis Chronic |
8.5% |
| Hypertension |
7.0% |
| Product Used For Unknown Indication |
7.0% |
| Cardiac Failure Congestive |
5.6% |
| Dizziness |
5.6% |
| Dyslipidaemia |
5.6% |
| Supraventricular Extrasystoles |
5.6% |
| Arrhythmia |
2.8% |
| Diabetes Mellitus |
2.8% |
| Epilepsy |
2.8% |
| Headache |
2.8% |
| Myocardial Infarction |
2.8% |
| Osteoporosis |
2.8% |
| Ventricular Tachycardia |
2.8% |
| Anticoagulant Therapy |
1.4% |
| Cardiac Valve Disease |
1.4% |
| Gastric Ulcer |
1.4% |
| Herpes Zoster |
1.4% |
|
| Long Qt Syndrome |
15.4% |
| Sinus Arrest |
15.4% |
| Torsade De Pointes |
15.4% |
| Ventricular Tachycardia |
15.4% |
| Acute Myocardial Infarction |
7.7% |
| Fall |
7.7% |
| Generalised Erythema |
7.7% |
| Mitral Valve Prolapse |
7.7% |
| Renal Impairment |
7.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.9% |
| Product Used For Unknown Indication |
10.7% |
| Atrial Fibrillation |
9.3% |
| Pulmonary Arterial Hypertension |
9.3% |
| Cardiac Failure |
6.4% |
| Idiopathic Thrombocytopenic Purpura |
6.0% |
| Hypertension |
5.4% |
| Rheumatoid Arthritis |
4.8% |
| Prophylaxis |
3.3% |
| Pulmonary Hypertension |
3.3% |
| Pyrexia |
3.3% |
| Herpes Zoster |
3.1% |
| Helicobacter Infection |
2.7% |
| Infection Prophylaxis |
2.5% |
| Insomnia |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Hyperuricaemia |
2.3% |
| Lung Transplant |
2.3% |
| Mitral Valve Incompetence |
2.3% |
| Emphysema |
1.9% |
|
| Hypoglycaemia |
8.5% |
| Subarachnoid Haemorrhage |
8.5% |
| International Normalised Ratio Increased |
7.0% |
| Malaise |
7.0% |
| Pulmonary Alveolar Haemorrhage |
5.6% |
| Renal Impairment |
5.6% |
| Somnolence |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Cellulitis |
4.2% |
| Coronary Artery Disease |
4.2% |
| Haemoglobin Decreased |
4.2% |
| Hepatic Function Abnormal |
4.2% |
| Pneumonia |
4.2% |
| Sepsis |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Weight Increased |
4.2% |
| Wrist Fracture |
4.2% |
| Arterial Occlusive Disease |
2.8% |
| Bronchial Neoplasm |
2.8% |
| C-reactive Protein Increased |
2.8% |
|
| Interacting |
| Atrial Fibrillation |
100.0% |
|
| Torsade De Pointes |
100.0% |
|
